. Author manuscript; available in PMC: 2018 Oct 26.

Published in final edited form as: J Autoimmun. 2016 May 6;75:30–38. doi: 10.1016/j.jaut.2016.04.008

Table 1.

Clinical and laboratory features of the patients used as a source of human aβ₂GPI antibodies (Pt1 - Pt7) and patients that received HCQ treatment (Pt 8 - Pt12). Pt indicates patient. All patients met Sidney Laboratory criteria for APS [28]. ACA= anticardiolipin, β₂=β₂gycoprotein I (β₂GPI), RM=recurrent miscarriages, APS= primary antiphospholipid syndrome, DVT=deep vein thrombosis, PE= pulmonary embolism.

	Sex/age	ACA-IgG	β₂GPI-IgG	LA	diagnostic	Clinical features	Obstetric APS
Pt 1	F/52	+	+	+	PAPS	arterial thrombosis	RM Stillbirth
Pt 2	M/62	+	+	+	PAPS	DVT, stroke
Pt 3	F/48	+	+	+	PAPS	DVT, PE	Preeclampsia
Pt 4	F/38	+	+	+	PAPS	DVT	RM preeclampsia
Pt 5	M/54	+	+	+	PAPS	arterial and venous thrombosis
Pt 6	F/54	+	+	+	PAPS	DVT	RM, preterm birth, stillbirth
Pt 7	F/45	+	+	+	PAPS		RM, preeclampsia
Pt 8	F/38	+	+	+	PAPS		RM Stillbirth
Pt 9	F/31	+	+	+	PAPS	DVT	RM IUGR
Pt 10	F/34	+	+	+	PAPS		Preeclampsia HELLP syndrome
Pt 11	F/32	+	+	+	PAPS		RM preeclampsia
Pt 12	F/34	+	+	+	PAPS	venous thrombosis	RM, preeclampsia